Page 118 - ESHRE2019

Learning objectives
Human embryonic stem cells (hESC)
Induced pluripotent stem cells (hiPSC)
Characterisation and quality control
Characterisation for clinical application
Clinical grade generation of hPSC and Good Manuphacturing Practice (GMP) Cell Therapy
The leading application for hPSC derivatives Clinical trials with hESC derivatives
Clinical trials with hiPSC
Conclusions
PCC Stem Cells - ESHRE Vienna 2019
Pluripotent Stem Cells can be obtained from cells located in the inner cell mass of blastocysts, early embryos and isolated blastomeres (hESC) and from nuclear reprogramming (Somatic Cell Nuclear Transfer - SCNTand induced Pluripotent Stem Cells - iPS)
PCC Stem Cells - ESHRE Vienna 2019
116
113